Clinical Trial Update: Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating methotrexate for arthritis caused by chikungunya virus. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Chikungunya

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: George Washington University | Conditions: Investigate the Effect(s) of Methotrexate Treatment on Arthritis Disease Severity | Phase 3 | Status: ACTIVE_NOT_RECRUITING